한국에서 전립샘암 병기별, 치료시기별 삶의 질 = Utilities for prostate cancer by cancer stage and treatment step in Korea

다국어 초록 (Multilingual Abstract)

This study was conducted to estimate the quality of life of the prostate cancer patients by cancer stage and treatment step in South Korea. Health scenarios including clinical symptoms and treatment complications that the prostate cancer patients may experience were developed through discussion with clinical experts and Korean Urological Association. A face-to-face survey using Time-Trade Off (TTO) to each imaginary health scenario was administered to 160 male subjects to measure the preference of general public. The results showed that the utility index was estimated to be 0.727 at the first year of treatment and 0.653 at the second year after local cancer diagnosis, 0.545 at the first year and 0.451 at the second year after locally advanced cancer diagnosis. For metastatic cancer diagnosis, the utility index was 0.321 in the first year and 0.149 in the second year. The utility index decreased by cancer stage, and it was lower in the management and follow up period than in intensive treatment period. Caution is needed to estimate the utility index by asking the general public using imaginary health scenarios, especially, about complex health status. The study would encourage discussion about estimating utility index for use of economic evaluation among health care researchers.

참고문헌 (Reference)

1 신상진, "한국 성인의 건강관련 삶의 질 특성분석" 서울대학교 보건대학원 2010

2 최진호, "전립선암 환자에서 치료 후 건강 관련 삶의 질 변화" 대한비뇨기과학회 45 (45): 878-889, 2004

3 건강보험심사평가원, "의약품 경제성평가지침」 및 작료작성 요령"

4 김수영, "삶의 질 측정도구의 번역" 19 (19): 1034-1042, 1998

5 박병주, "근거중심보건의료" 고려의학 2009

6 Boyd, N.F., "Whose utilities for decision analysis?" 10 (10): 58-67, 1990

7 Krahn, M. D., "Utility and health-related quality of life in prostate cancer patients 12 months after radical prostatectomy or radiation therapy" 12 (12): 361-368, 2009

8 Stewart, S. T., "Utilities for prostate cancer health states in men aged 60 and older" 43 (43): 347-355, 2005

9 Lee, Y. K., "South Korean Time Trade-Off Values for EQ-5D Health States : Modeling with Observed Values for 101 Health States" 12 (12): 1187-1193, 2009

10 Krahn, M. D, "Responsiveness of disease-specific and generic utility instruments in prostate cancer patients" 16 (16): 509-522, 2007

11 Krahn, M. D,, "Patient and community preferences for outcomes in prostate cancer : implications for clinical policy" 41 (41): 153-164, 2003

12 Saigal, C., "Patient Utilities for Complications Do Not Predict Treatment Choice in Men with Clinically Localized Prostate Cancer" 8 (8): 17-22, 2001

13 Pharmaceutical Benefits Advisory Committee, "Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee(Version 4.3)" Commonwealth of Australia 2008

14 Jo, M. W., "Estimating Quality Weights for EQ-5D Health States with the Time Trade-off Method in South Korea" 11 (11): 1186-1189, 2008

15 Rascati, K.L., "Essentials of Pharmacoeconomics" Lippincott Willianms & Wilkins, a Wolters Kluwer business 2009

16 강은정, "EQ-5D를 이용한 건강수준의 가치 평가" 한국보건경제정책학회 12 (12): 19-43, 2006

17 정경진, "Development and Validation of the Korean Version of Expanded Prostate Cancer Index Composite: Questionnaire Assessing Health-Related Quality of Life after Prostate Cancer Treatment" 대한비뇨기과학회 51 (51): 601-612, 2010

18 Ku, J., "Changes in health utilities and health-related quality of life over 12 months following radical prostatectomy" 3 (3): 445-452, 2009

19 Jayadevappa, R., "Association between utility and treatment among patients with prostate cancer" 19 (19): 711-720, 2010

20 Gray, A. M., "Applied Methods of Cost-effectiveness Analysis in Health Care" Oxford University Press 2011

21 Bremner, K. E., "A review and meta-analysis of prostate cancer utilities" 27 (27): 288-298, 2007